Niealkoholowa choroba stłuszczeniowa wątroby
Charakterystyka, pielęgnacja i opieka

Niealkoholowa stłuszczeniowa choroba wątroby (NAFLD/MASLD) to najczęstsza przewlekła choroba wątroby w krajach zachodnich, dotykająca 30-40% dorosłych w USA. Obejmuje spektrum od prostego stłuszczenia (NAFL) do niealkoholowego stłuszczeniowego zapalenia wątroby (NASH), które może prowadzić do włóknienia, marskości, niewydolności wątroby oraz raka wątrobowokomórkowego. Choroba jest silnie powiązana z otyłością, cukrzycą typu 2, dyslipidemią i zespołem metabolicznym. Diagnostyka opiera się na wykluczeniu innych przyczyn stłuszczenia, badaniach laboratoryjnych (ALT, AST, bilirubina, albuminy, czas protrombinowy, glukoza, lipidy), obrazowych (USG, CT, MRI) oraz nieinwazyjnych markerach włóknienia (FIB-4, NAFLD Fibrosis Score, elastografia). Biopsja wątroby pozostaje złotym standardem, choć stosowana jest selektywnie ze względu na inwazyjność.

Niealkoholowa stłuszczeniowa choroba wątroby – definicja i charakterystyka

Niealkoholowa stłuszczeniowa choroba wątroby (NAFLD, obecnie nazywana również MASLD – metabolic dysfunction-associated steatotic liver disease) to schorzenie charakteryzujące się nadmiernym gromadzeniem tłuszczu w wątrobie, które nie jest spowodowane spożywaniem alkoholu. Jest to najczęstsza przewlekła choroba wątroby w krajach zachodnich, dotykająca około 30-40% populacji dorosłych w Stanach Zjednoczonych.12

NAFLD obejmuje spektrum schorzeń wątrobowych – od prostego stłuszczenia wątroby (NAFL) po niealkoholowe stłuszczeniowe zapalenie wątroby (NASH), które jest agresywną formą choroby charakteryzującą się stanem zapalnym i może prowadzić do włóknienia, marskości oraz niewydolności wątroby. W ciężkich przypadkach może być przyczyną raka wątrobowokomórkowego.34

Choroba ta często rozwija się u osób z nadwagą, otyłością, cukrzycą typu 2, podwyższonym poziomem cholesterolu lub trójglicerydów. NAFLD jest również ściśle powiązana z zespołem metabolicznym, co podkreśla jej systemowy charakter i konieczność wielodyscyplinarnego podejścia w opiece nad pacjentem.5

Objawy kliniczne

NAFLD zwykle przebiega bezobjawowo, szczególnie we wczesnych stadiach choroby. U większości pacjentów nie występują żadne specyficzne symptomy, dopóki choroba nie osiągnie zaawansowanego stadium, takiego jak marskość wątroby. Gdy objawy się pojawiają, mogą obejmować:67

  • Zmęczenie i osłabienie
  • Ból w prawym górnym kwadrancie brzucha
  • Obrzęk brzucha (wodobrzusze)
  • Obrzęk kończyn dolnych
  • Zaburzenia funkcji poznawczych (pamięci, uwagi, koncentracji)
  • Zażółcenie skóry i oczu (żółtaczka)
  • Ciemny mocz
  • Świąd skóry

Należy podkreślić, że pacjenci mogą mieć zaawansowaną chorobę wątroby bez widocznych objawów klinicznych, co podkreśla znaczenie wczesnej diagnozy i interwencji, szczególnie u osób z grupy wysokiego ryzyka.8

Ocena pielęgniarska i diagnoza NAFLD

Pielęgniarki odgrywają kluczową rolę w identyfikacji pacjentów z ryzykiem rozwoju NAFLD oraz w kompleksowej ocenie ich stanu zdrowia. Rozpoznanie choroby często następuje przypadkowo podczas rutynowych badań, dlatego dokładna ocena pielęgniarska jest niezbędna dla wczesnej identyfikacji schorzenia.910

Ocena czynników ryzyka

Pielęgniarska ocena pacjenta z podejrzeniem NAFLD powinna obejmować identyfikację czynników ryzyka, takich jak:11

  • Nadwaga lub otyłość (zwłaszcza z akumulacją tłuszczu trzewnego)
  • Cukrzyca typu 2 lub stan przedcukrzycowy
  • Podwyższony poziom cholesterolu i trójglicerydów
  • Nadciśnienie tętnicze
  • Zespół metaboliczny
  • Wywiad rodzinny w kierunku NAFLD
  • Siedzący tryb życia
  • Dieta bogata w przetworzone węglowodany i tłuszcze nasycone

Metody diagnostyczne

Diagnoza NAFLD wymaga wykluczenia innych przyczyn stłuszczenia wątroby, takich jak spożywanie alkoholu czy przyjmowanie leków hepatotoksycznych. Pielęgniarki powinny być zaznajomione z podstawowymi metodami diagnostycznymi, które obejmują:1213

  • Badania laboratoryjne: ocena enzymów wątrobowych (ALT, AST), bilirubiny, albuminy, czasu protrombinowego, poziomu glukozy na czczo, lipidów
  • Badania obrazowe: USG jamy brzusznej (najczęściej stosowane), tomografia komputerowa (CT), rezonans magnetyczny (MRI)
  • Nieinwazyjne markery włóknienia: skala FIB-4, NAFLD Fibrosis Score (NFS), elastografia przejściowa (Fibroscan)
  • Biopsja wątroby – nadal złoty standard diagnostyczny do oceny stopnia zaawansowania choroby, jednak ze względu na inwazyjność nie jest rutynowo stosowana

Pielęgniarki powinny rozumieć znaczenie wyników tych badań i potrafić wyjaśnić ich znaczenie pacjentom, aby zwiększyć ich świadomość dotyczącą stanu zdrowia.14

Interwencje pielęgniarskie w opiece nad pacjentem z NAFLD

Opieka pielęgniarska nad pacjentem z NAFLD obejmuje szereg interwencji ukierunkowanych na modyfikację stylu życia, edukację pacjenta oraz wsparcie w zarządzaniu chorobą i jej powikłaniami. Pielęgniarki są w strategicznej pozycji, aby edukować pacjentów i ich rodziny na temat NAFLD/NASH oraz współpracować z innymi członkami zespołu opieki zdrowotnej.15

Wspieranie modyfikacji stylu życia

Podstawą leczenia NAFLD jest modyfikacja stylu życia, a pielęgniarki odgrywają kluczową rolę w tym procesie:1617

  • Redukcja masy ciała: Pomoc pacjentom w opracowaniu realistycznego planu redukcji masy ciała. Utrata już 3-5% masy ciała może przynieść korzyści, ale zaleca się redukcję o co najmniej 10% w celu odwrócenia procesów patologicznych w wątrobie. Kluczowe jest zmniejszenie liczby spożywanych kalorii.
  • Poradnictwo dietetyczne: Promowanie zdrowego odżywiania, które obejmuje:
    • Ograniczenie prostych węglowodanów (białe pieczywo, słodzone napoje)
    • Zwiększenie spożycia błonnika, warzyw, owoców i pełnych ziaren
    • Ograniczenie tłuszczów nasyconych i trans
    • Preferowanie tłuszczów nienasyconych (np. oliwa z oliwek, ryby)
    • Zalecanie diety śródziemnomorskiej lub DASH
  • Aktywność fizyczna: Zachęcanie do regularnej aktywności fizycznej, co najmniej 150 minut tygodniowo aktywności umiarkowanej. Stopniowe zwiększanie intensywności i czasu trwania ćwiczeń, zawsze po konsultacji z lekarzem.

Edukacja pacjenta

Pielęgniarki pełnią kluczową rolę w edukacji pacjentów z NAFLD na temat:1819

  • Choroby i jej konsekwencji: Wyjaśnienie, czym jest NAFLD, jakie są jego potencjalne powikłania i dlaczego modyfikacja stylu życia jest kluczowa
  • Samodzielnego monitorowania: Nauka pacjentów, jak monitorować postępy w redukcji masy ciała, kontrolować poziom glukozy (w przypadku cukrzycy) i obserwować objawy progresji choroby
  • Przyjmowania leków: Edukacja dotycząca prawidłowego stosowania przepisanych leków oraz potencjalnych interakcji i działań niepożądanych
  • Unikania czynników szkodliwych dla wątroby: Podkreślanie znaczenia unikania alkoholu i niektórych leków bez recepty, które mogą dodatkowo uszkadzać wątrobę
  • Szczepień ochronnych: Informowanie o zalecanych szczepieniach przeciwko WZW typu A i B, które są szczególnie ważne dla pacjentów z chorobami wątroby

Monitorowanie i zarządzanie chorobami współistniejącymi

Pacjenci z NAFLD często cierpią na inne schorzenia metaboliczne, które wymagają jednoczesnego leczenia. Pielęgniarki powinny wspierać pacjentów w zarządzaniu tymi stanami:2021

  • Cukrzyca: Monitorowanie poziomu glukozy we krwi, edukacja dotycząca insulinoterapii, rozpoznawanie objawów hipo- i hiperglikemii
  • Dyslipidemie: Wsparcie w przestrzeganiu diety niskocholesterolowej, monitorowanie poziomów lipidów
  • Nadciśnienie tętnicze: Regularny pomiar ciśnienia krwi, edukacja dotycząca znaczenia przestrzegania zaleceń terapeutycznych
  • Zespół metaboliczny: Kompleksowe podejście do zarządzania wszystkimi komponentami zespołu metabolicznego

Pielęgniarki powinny prowadzić ścisłe monitorowanie bilansu płynów, szczególnie u pacjentów z wodobrzuszem, oraz współpracować z dietetykiem w celu opracowania planu żywieniowego uwzględniającego preferencje i ograniczenia pacjenta.22

Wielodyscyplinarne podejście w opiece nad pacjentem z NAFLD

Ze względu na złożoność NAFLD i jej systemowy charakter, skuteczna opieka wymaga współpracy specjalistów z różnych dziedzin. Pielęgniarki odgrywają kluczową rolę w koordynacji tej opieki i zapewnieniu ciągłości leczenia.2324

Współpraca zespołowa

Efektywna opieka nad pacjentem z NAFLD wymaga współpracy między:2526

  • Lekarzem podstawowej opieki zdrowotnej: Koordynacja opieki, wstępna diagnostyka, monitorowanie postępów
  • Hepatologiem/gastroenterologiem: Specjalistyczna ocena i leczenie choroby wątroby
  • Endokrynologiem: Leczenie cukrzycy i innych zaburzeń metabolicznych
  • Dietetykiem: Opracowanie spersonalizowanych planów żywieniowych
  • Fizjoterapeutą: Projektowanie programów aktywności fizycznej dostosowanych do możliwości pacjenta
  • Pielęgniarką: Koordynacja opieki, edukacja, wsparcie w modyfikacji stylu życia
  • Psychologiem: Wsparcie w trudnościach związanych ze zmianą nawyków i radzeniem sobie z przewlekłą chorobą

Pielęgniarki mogą pełnić funkcję łącznika między różnymi specjalistami, zapewniając spójne podejście do leczenia i przekazywanie informacji między członkami zespołu terapeutycznego.27

Zapewnienie ciągłości opieki

Długoterminowa opieka nad pacjentem z NAFLD jest kluczowa dla osiągnięcia i utrzymania pozytywnych wyników leczenia. Pielęgniarki powinny:2829

  • Planować regularne wizyty kontrolne w celu monitorowania progresji choroby
  • Zapewnić ciągłość edukacji i wsparcia w modyfikacji stylu życia
  • Pomagać pacjentom w przezwyciężaniu barier w przestrzeganiu zaleceń
  • Koordynować opiekę między różnymi specjalistami
  • Dostosowywać plany opieki do zmieniających się potrzeb pacjenta

Pielęgniarki powinny być świadome, że zarządzanie NAFLD to proces długoterminowy, wymagający cierpliwości i systematycznej pracy zarówno ze strony pacjenta, jak i zespołu medycznego.30

Specyficzne interwencje pielęgniarskie w zaawansowanym NAFLD

W przypadku pacjentów z zaawansowaną postacią NAFLD, zwłaszcza z progresją do NASH lub marskości wątroby, opieka pielęgniarska musi być bardziej intensywna i ukierunkowana na zapobieganie i zarządzanie powikłaniami.31

Monitorowanie i zarządzanie powikłaniami

Pielęgniarki powinny być przygotowane do rozpoznawania i zarządzania następującymi powikłaniami:3233

  • Wodobrzusze: Monitorowanie obwodu brzucha, bilansu płynów, edukacja dotycząca ograniczenia sodu w diecie
  • Encefalopatia wątrobowa: Ocena stanu świadomości, funkcji poznawczych, edukacja rodziny dotycząca rozpoznawania wczesnych objawów
  • Krwawienie z żylaków przełyku: Monitorowanie objawów krwawienia z przewodu pokarmowego, edukacja pacjenta dotycząca unikania NLPZ i innych leków zwiększających ryzyko krwawienia
  • Zespół wątrobowo-nerkowy: Ścisłe monitorowanie funkcji nerek, bilansu płynów
  • Rak wątrobowokomórkowy: Edukacja dotycząca znaczenia regularnych badań przesiewowych

Opieka paliatywna i przygotowanie do przeszczepu

W zaawansowanych stadiach NAFLD, gdy dochodzi do niewydolności wątroby, pielęgniarki mogą być zaangażowane w:3435

  • Przygotowanie pacjenta do ewentualnego przeszczepu wątroby
  • Edukację dotyczącą procesu kwalifikacji do przeszczepu
  • Zapewnienie opieki paliatywnej skupionej na poprawie jakości życia
  • Wsparcie psychologiczne dla pacjenta i rodziny
  • Zarządzanie objawami związanymi z zaawansowaną chorobą wątroby

Edukacja i prewencja NAFLD

Pielęgniarki mają unikalną możliwość promowania zdrowego stylu życia i edukacji na temat profilaktyki NAFLD, zarówno wśród pacjentów z grupy ryzyka, jak i populacji ogólnej.36

Strategie profilaktyczne

Edukacja w zakresie profilaktyki NAFLD powinna koncentrować się na:3738

  • Zdrowej diecie: Promocja diety bogatej w owoce, warzywa, pełne ziarna i zdrowe tłuszcze, z ograniczeniem cukrów prostych i tłuszczów nasyconych
  • Utrzymaniu prawidłowej masy ciała: Edukacja na temat znaczenia utrzymania BMI w zakresie 18,5-24,9
  • Regularnej aktywności fizycznej: Zachęcanie do minimum 150 minut tygodniowo aktywności umiarkowanej
  • Unikaniu alkoholu: Podkreślanie, że nawet małe ilości alkoholu mogą pogorszyć stan wątroby u osób z NAFLD
  • Regularnych badaniach kontrolnych: Promowanie znaczenia badań przesiewowych u osób z grup ryzyka

Ukierunkowana edukacja dla grup ryzyka

Szczególną uwagę należy poświęcić edukacji grup wysokiego ryzyka, takich jak:3940

  • Osoby z otyłością: Szczegółowe poradnictwo w zakresie redukcji masy ciała i zmiany nawyków żywieniowych
  • Pacjenci z cukrzycą typu 2: Edukacja na temat związku między kontrolą glikemii a zdrowiem wątroby
  • Osoby z zespołem metabolicznym: Kompleksowe podejście do wszystkich składowych zespołu
  • Młodzież i dzieci z otyłością: Wczesna interwencja i edukacja rodzin dotycząca zdrowego stylu życia
  • Kobiety ciężarne z czynnikami ryzyka: Dostosowane poradnictwo dotyczące zarządzania NAFLD w okresie ciąży

Pielęgniarki mogą organizować zajęcia edukacyjne, tworzyć materiały informacyjne i prowadzić indywidualne sesje edukacyjne dostosowane do potrzeb poszczególnych grup pacjentów.41

Poprawa jakości opieki nad pacjentami z NAFLD

Pielęgniarki mogą aktywnie uczestniczyć w inicjatywach mających na celu poprawę jakości opieki nad pacjentami z NAFLD poprzez standaryzację procesów, wdrażanie wytycznych klinicznych i ciągłe doskonalenie praktyki pielęgniarskiej.42

Wdrażanie pakietów opieki (care bundles)

Pakiety opieki to zestawy opartych na dowodach praktyk, które gdy są stosowane razem, poprawiają wyniki leczenia. W kontekście NAFLD, pakiety opieki mogą obejmować:4344

  • Standaryzowane protokoły oceny pacjentów z NAFLD
  • Algorytmy leczenia oparte na dowodach naukowych
  • Listy kontrolne do dokumentowania kluczowych aspektów opieki
  • Narzędzia do monitorowania i zarządzania czynnikami ryzyka metabolicznego
  • Protokoły współpracy interdyscyplinarnej

Badania wykazały, że wdrożenie pakietów opieki w ambulatoryjnych klinikach znacząco poprawia zarządzanie pacjentami z NAFLD i zwiększa prawdopodobieństwo kompleksowego podejścia do leczenia.45

Ciągła edukacja personelu pielęgniarskiego

W miarę rozwoju wiedzy na temat NAFLD, pielęgniarki powinny angażować się w ciągłą edukację, aby utrzymać aktualne kompetencje w zakresie:4647

  • Najnowszych wytycznych diagnostycznych i terapeutycznych
  • Nowych metod nieinwazyjnej oceny włóknienia wątroby
  • Innowacyjnych podejść do modyfikacji stylu życia
  • Nowo zatwierdzonych terapii farmakologicznych
  • Strategii poprawy współpracy pacjentów w leczeniu

Pielęgniarki mogą uczestniczyć w kursach, konferencjach, webinariach oraz dołączać do profesjonalnych stowarzyszeń koncentrujących się na chorobach wątroby, aby być na bieżąco z najnowszymi osiągnięciami w dziedzinie opieki nad pacjentami z NAFLD.48

Badania pielęgniarskie w obszarze NAFLD

Pielęgniarki mogą wnosić znaczący wkład w badania nad NAFLD, oceniając efektywność interwencji pielęgniarskich, identyfikując bariery w opiece i opracowując innowacyjne strategie poprawy wyników leczenia.49

Obszary badawcze

Potencjalne obszary badań pielęgniarskich związanych z NAFLD obejmują:5051

  • Ocenę efektywności różnych strategii edukacyjnych w poprawie przestrzegania zaleceń przez pacjentów
  • Badanie wpływu prowadzonych przez pielęgniarki programów zarządzania wagą na wyniki leczenia NAFLD
  • Ocenę roli pielęgniarek w koordynacji opieki multidyscyplinarnej
  • Identyfikację barier w dostępie do opieki dla pacjentów z NAFLD
  • Opracowanie i walidację narzędzi oceny pielęgniarskiej dla pacjentów z NAFLD
  • Badanie doświadczeń pacjentów z NAFLD i ich potrzeb w zakresie wsparcia psychospołecznego

Wyniki tych badań mogą przyczynić się do rozwoju opartych na dowodach protokołów opieki pielęgniarskiej i poprawy jakości życia pacjentów z NAFLD.52

Szczególne aspekty opieki nad wybranymi grupami pacjentów

Niektóre grupy pacjentów z NAFLD wymagają specjalnego podejścia w opiece pielęgniarskiej ze względu na specyficzne potrzeby i wyzwania.53

Dzieci i młodzież z NAFLD

Niealkoholowa stłuszczeniowa choroba wątroby dotyka coraz częściej dzieci i młodzież, głównie w związku z rosnącą częstością występowania otyłości w tej grupie wiekowej. Opieka pielęgniarska nad pediatrycznymi pacjentami z NAFLD wymaga:5455

  • Zaangażowania całej rodziny w proces modyfikacji stylu życia
  • Dostosowania zaleceń dietetycznych i aktywności fizycznej do wieku i możliwości dziecka
  • Szczególnej uwagi na aspekty psychologiczne związane z nadwagą i przewlekłą chorobą
  • Współpracy ze szkołą w celu zapewnienia wsparcia
  • Długoterminowego wsparcia w utrzymaniu zdrowych nawyków, ponieważ NAFLD stanowi wyzwanie na całe życie

Kobiety ciężarne z NAFLD

NAFLD może mieć specyficzne implikacje podczas ciąży. Opieka pielęgniarska powinna uwzględniać:56

  • Dostosowanie interwencji modyfikujących styl życia do wymogów okresu ciąży
  • Monitorowanie wpływu NAFLD na przebieg ciąży
  • Współpracę z położnikiem w celu optymalizacji opieki prenatalnej
  • Edukację dotyczącą bezpiecznych form aktywności fizycznej w ciąży
  • Ścisłe monitorowanie podczas ciąży w celu zmniejszenia ryzyka i poprawy wyników zarówno dla matki, jak i dziecka

Pacjenci w podeszłym wieku

Osoby starsze z NAFLD mogą wymagać specjalnego podejścia ze względu na współistniejące schorzenia i ograniczenia funkcjonalne:57

  • Dostosowanie planów aktywności fizycznej do możliwości i ograniczeń fizycznych
  • Szczególną uwagę na potencjalne interakcje lekowe
  • Monitorowanie funkcji poznawczych, które mogą być bardziej podatne na zaburzenia w przypadku zaawansowanej choroby wątroby
  • Wsparcie w codziennych czynnościach i przestrzeganiu zaleceń
  • Dostosowanie metod edukacji do specyficznych potrzeb osób starszych

Telemedycyna i narzędzia cyfrowe w opiece nad pacjentem z NAFLD

Rozwój technologii cyfrowych stwarza nowe możliwości w opiece nad pacjentami z NAFLD, a pielęgniarki mogą wykorzystywać te narzędzia do poprawy dostępu do opieki i wsparcia pacjentów w samodzielnym zarządzaniu chorobą.58

Zastosowania telemedycyny

Telemedycyna może być wykorzystywana w opiece nad pacjentami z NAFLD w następujący sposób:59

  • Zdalne konsultacje i monitorowanie pacjentów, szczególnie tych mieszkających w odległych obszarach
  • Wirtualne sesje edukacyjne i warsztaty dotyczące zdrowego stylu życia
  • Regularne kontrole bez konieczności osobistej wizyty w placówce
  • Interdyscyplinarne konsultacje z udziałem specjalistów z różnych ośrodków
  • Wsparcie psychologiczne i motywacyjne

Narzędzia cyfrowe wspierające samozarządzanie

Pielęgniarki mogą rekomendować i pomagać pacjentom w korzystaniu z narzędzi cyfrowych, takich jak:60

  • Aplikacje mobilne do monitorowania diety, aktywności fizycznej i masy ciała
  • Platformy edukacyjne zawierające materiały informacyjne o NAFLD
  • Systemy przypominające o przyjmowaniu leków i wizytach kontrolnych
  • Elektroniczne dzienniki do śledzenia objawów i postępów leczenia
  • Wirtualne grupy wsparcia dla pacjentów z NAFLD

Pielęgniarki powinny pomagać pacjentom w wyborze wiarygodnych i opartych na dowodach naukowych narzędzi cyfrowych oraz edukować ich w zakresie efektywnego korzystania z tych rozwiązań.61

Podsumowanie rekomendacji dla praktyki pielęgniarskiej

Opieka pielęgniarska nad pacjentami z niealkoholową stłuszczeniową chorobą wątroby wymaga kompleksowego podejścia, które obejmuje edukację, wsparcie w modyfikacji stylu życia, koordynację opieki multidyscyplinarnej oraz monitorowanie postępu choroby i potencjalnych powikłań.62

Kluczowe rekomendacje

Na podstawie aktualnych wytycznych i badań, można sformułować następujące rekomendacje dla praktyki pielęgniarskiej:6364

  • Aktywnie identyfikować pacjentów z grupy ryzyka NAFLD, szczególnie osoby z otyłością, cukrzycą typu 2 i zespołem metabolicznym
  • Prowadzić kompleksową ocenę stanu pacjenta, uwzględniając nie tylko aspekty fizyczne, ale również psychospołeczne
  • Opracowywać spersonalizowane plany opieki, dostosowane do indywidualnych potrzeb i możliwości pacjenta
  • Wspierać pacjentów w stopniowej redukcji masy ciała poprzez zmiany dietetyczne i zwiększenie aktywności fizycznej
  • Edukować pacjentów na temat choroby, jej konsekwencji i znaczenia modyfikacji stylu życia
  • Koordynować opiekę multidyscyplinarną, zapewniając ciągłość i spójność działań terapeutycznych
  • Monitorować postęp choroby i skuteczność interwencji, dostosowując plan opieki w razie potrzeby
  • Wspierać pacjentów w zarządzaniu chorobami współistniejącymi, które mogą wpływać na progresję NAFLD
  • Wykorzystywać narzędzia cyfrowe i telemedycynę do poprawy dostępu do opieki i wsparcia samozarządzania
  • Angażować się w ciągłą edukację i badania, aby doskonalić praktykę pielęgniarską w obszarze NAFLD

Wdrożenie tych rekomendacji może przyczynić się do poprawy jakości opieki nad pacjentami z NAFLD i pomóc w zatrzymaniu lub odwróceniu progresji choroby, zapobiegając poważnym powikłaniom.65

Kolejne rozdziały

Zapraszamy do dalszego czytania naszego leksykonu.

Wybierz kolejny rozdział z menu poniżej, aby otworzyć nową podstronę kompedium wiedzy i uzyskać szczegółowe informację o leku, substancji lub chorobie.

  1. 11.04.2026
  2. www.leksykon.com.pl

Materiały źródłowe

  • #1 Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
    https://my.clevelandclinic.org/health/diseases/22437-non-alcoholic-fatty-liver-disease
    Metabolic dysfunction-associated steatotic liver disease (MASLD) is when fat builds up in your liver. It once was called nonalcoholic fatty liver disease (NAFLD). […] Losing weight and becoming more active may slow down or reverse liver damage from MASLD. […] Treatment for MASLD usually starts with weight loss. Your healthcare provider will also treat conditions like diabetes, high cholesterol and high blood pressure, which cause MASLD. […] Losing weight makes a difference in your liver health. Reducing excess fat in your liver helps with inflammation that leads to cirrhosis. […] Your provider may recommend meal plans like the Mediterranean diet or the DASH diet. […] Doing moderate activity 30 minutes a day for three days a week supports weight loss. […] Your provider may recommend you lose 10% or more of your body weight. But even losing 3% to 5% of your weight can make a difference.
  • #2 Fatty Liver Disease: Nonalcoholic and Alcoholic Steatohepatitis (NAFLD/AFLD)
    https://www.webmd.com/fatty-liver-disease/fatty-liver-disease
    Fatty liver disease (FLD) means you have extra fat in your liver. You might hear your doctor call it hepatic steatosis. Most of the time, it doesn’t cause symptoms, but over time a buildup of fat makes it harder for your liver to work. […] With diet and exercise, fatty liver disease can be reversed. […] This type used to be called nonalcoholic fatty liver disease (NAFLD). It is very common in the U.S., affecting 1 in 3 adults. […] Unlike the other main type, you don’t get it from drinking alcohol. […] Most people with MASLD have simple fatty liver. […] This used to be known as nonalcoholic steatohepatitis (NASH). It’s the advanced stage of FLD and means you have inflammation in your liver. […] These problems can lead to liver failure and require a liver transplant. […] If you have complications due to either type of FLD, such as cirrhosis or liver failure, you may need to have a liver transplant.
  • #3 Nonalcoholic fatty liver – La Crosse – Mayo Clinic Health System
    https://www.mayoclinichealthsystem.org/locations/la-crosse/services-and-treatments/gastroenterology-and-hepatology/digestive-disorders/nonalcoholic-fatty-liver-disease
    Nonalcoholic fatty liver disease is a term for a range of liver conditions. As the name implies, the main characteristic the disease is too much fat stored in liver cells. […] Some individuals with nonalcoholic fatty liver disease can develop nonalcoholic steatohepatitis, which is an aggressive form of fatty liver disease marked by liver inflammation that may progress to advanced scarring, or cirrhosis, and liver failure. This damage is similar to the damage caused by heavy alcohol use. […] Nonalcoholic fatty liver disease usually causes no signs and symptoms unless cirrhosis is present, including: Abdominal swelling, Lower extremity swelling (edema), Impaired mental abilities (memory, attention, concentration), Yellowing of the skin and eyes (jaundice), Dark urine, Itching (pruritus).
  • #4 Non-Alcoholic Fatty Liver Disease | University of Michigan Health
    https://www.uofmhealth.org/conditions-treatments/digestive-and-liver-health/fatty-liver-disease-non-alcoholic
    NAFLD can be separated into two categories: […] NASH is a progressive form of NAFLD where inflammation causes liver damage and scarring (fibrosis). […] Patients who develop cirrhosis are at risk for complications including liver failure and liver cancer (hepatocellular carcinoma). […] In addition to liver-related complications, patients with NAFLD and NASH are also at higher-than-usual risk for cardiovascular disease. […] Diagnosis is typically made if testing for other causes of liver disease is negative and there are findings of fat deposition on imaging tests (like ultrasound, CAT scan or MRI). […] Liver biopsy is the only way to accurately differentiate between NAFLD and NASH. […] Active research is ongoing, but for now there are no FDA approved medications specifically for the treatment of NAFLD/NASH.
  • #5 Nonalcoholic Fatty Liver Disease (NAFLD)
    https://liverfoundation.org/liver-diseases/fatty-liver-disease/nonalcoholic-fatty-liver-disease-nafld/
    Nonalcoholic fatty liver disease (NAFLD), now called metabolic dysfunction-associated steatotic liver disease (MASLD), is the buildup of extra fat in liver cells that is not caused by alcohol. […] Nonalcoholic fatty liver disease (now known as MASLD) tends to develop in people who are overweight or obese or have diabetes, high cholesterol, or high triglycerides. […] Current medical recommendations suggest the importance of discussing the NAFLD/heart disease connection with a health care provider if you have NAFLD. […] Early diagnosis of NAFLD, along with following medical advice, can reduce a persons chance NAFLD progressing to NASH and cirrhosis. […] There are no medications approved yet for nonalcoholic fatty liver disease (now called MASLD). Eating a healthy diet and adding physical movement to your day may help prevent liver damage from starting or reverse it in the initial stages.
  • #6 Nonalcoholic fatty liver – La Crosse – Mayo Clinic Health System
    https://www.mayoclinichealthsystem.org/locations/la-crosse/services-and-treatments/gastroenterology-and-hepatology/digestive-disorders/nonalcoholic-fatty-liver-disease
    Nonalcoholic fatty liver disease is a term for a range of liver conditions. As the name implies, the main characteristic the disease is too much fat stored in liver cells. […] Some individuals with nonalcoholic fatty liver disease can develop nonalcoholic steatohepatitis, which is an aggressive form of fatty liver disease marked by liver inflammation that may progress to advanced scarring, or cirrhosis, and liver failure. This damage is similar to the damage caused by heavy alcohol use. […] Nonalcoholic fatty liver disease usually causes no signs and symptoms unless cirrhosis is present, including: Abdominal swelling, Lower extremity swelling (edema), Impaired mental abilities (memory, attention, concentration), Yellowing of the skin and eyes (jaundice), Dark urine, Itching (pruritus).
  • #7 Nonalcoholic fatty liver disease: MedlinePlus Medical EncyclopediaLock
    https://medlineplus.gov/ency/article/007657.htm
    Nonalcoholic fatty liver disease (NAFLD) is the buildup of fat in the liver that is not caused by drinking too much alcohol. People who have it do not have a history of heavy drinking. NAFLD is usually but not always related to being overweight. […] There is no specific treatment for NAFLD. The goal is to manage your risk factors and any health conditions. […] Your provider will help you understand your condition and the healthy choices that can help you take care of your liver. These may include: […] Losing weight if you are overweight. […] Eating a healthy diet that is low in salt. […] Not drinking alcohol. […] Staying physically active. […] Managing health conditions such as diabetes and high blood pressure. […] Getting vaccinated for diseases such as hepatitis A and hepatitis B.
  • #8 Nonalcoholic fatty liver disease: from pathogenesis to patient care | Nature Reviews Endocrinology
    https://www.nature.com/articles/ncpendmet0505
    Nonalcoholic fatty liver disease (NAFLD) is the most common liver disease in Western countries. […] Clinical symptoms are nonspecific and are frequently absent in patients without cirrhosis. […] Liver biopsy remains the gold standard for evaluation of prognosis. […] NAFLD can progress to cirrhosis and hepatocellular carcinoma. […] Lifestyle changes, such as dietary modifications and exercise, are recommended.
  • #9 Practice Nursing – Non-alcoholic fatty liver disease: a global concern
    https://www.practicenursing.com/content/clinical-focus/non-alcoholic-fatty-liver-disease-a-global-concern/
    Non-alcoholic fatty liver disease is an umbrella term used to describe a build-up of fat in the liver. […] Nurses are often in the best position to prompt early investigation. Health promotion in the form of lifestyle advice is the mainstay of treatment, with an emphasis on weight reduction and healthy diet.
  • #10
    https://www.nursingcenter.com/journalarticle?Article_ID=5473730&Journal_ID=54016&Issue_ID=5473671
    Nonalcoholic fatty liver disease (NAFLD) is defined as storage of excess fat in the liver not caused by heavy alcohol consumption. Nonalcoholic steatohepatitis is the severe form of NAFLD. This article discusses causes, diagnosis, and nursing interventions for patients with either disorder. […] This article discusses causes, diagnosis, and nursing interventions for patients with NAFLD and NASH. […] A fundamental component of NAFLD and NASH management is lifestyle modification. Importantly, this includes avoiding alcohol, a known hepatotoxin, to prevent further liver damage. […] Nurses are in a strategic position to educate patients, caregivers, and families about NAFLD and NASH. Collaborating with healthcare team members in other disciplines, nurses can work with patients and families to develop a practical plan of care that will help patients lose and maintain weight, make informed dietary choices, and manage comorbidities such as diabetes.
  • #11
    https://journals.lww.com/nursing/fulltext/2020/03000/nonalcoholic_fatty_liver_disease__what_nurses_need.11.aspx
    Nonalcoholic fatty liver disease: What nurses need to know […] GENERAL PURPOSE: To provide an overview of NAFLD. […] LEARNING OBJECTIVES/OUTCOMES: After completing this continuing-education activity, you should be able to: 1. Describe risk factors for NAFLD. 2. List the clinical manifestations of NAFLD. 3. Outline nursing interventions for patients with NAFLD. […] […] […] Nutritional recommendations for patients with NAFLD include having 40% to 50% of total dietary intake comprised of carbohydrates. […] […] […] Which of the following supplements does the AASLD recommend considering for adults without diabetes who have biopsy-proven NASH? vitamin E. […] […] […] A diet rich in which of the following has been proven beneficial for patients with NAFLD and NASH? whole grains. […] […] […] To resolve mild-to-moderate fibrosis, the AASLD recommends that patients reduce body weight by 5%.
  • #12 Nonalcoholic Fatty Liver Disease: Common Questions and Answers on Diagnosis and Management | AAFP
    https://www.aafp.org/pubs/afp/issues/2020/1115/p603.html
    Nonalcoholic fatty liver disease (NAFLD) is the most common form of liver disease in the United States, affecting up to 30% of adults. […] Weight loss through diet and exercise is the primary treatment for NAFLD. […] A liver biopsy should be offered to patients with NAFLD who are at increased risk of nonalcoholic steatohepatitis or advanced fibrosis based on noninvasive testing or if noninvasive testing cannot rule out other possible causes of chronic liver disease. […] Routine screening for NAFLD is not recommended, even in high-risk adults, because of uncertainties surrounding diagnostic tests and treatment options, and the lack of knowledge related to the long-term benefits and cost-effectiveness of screening. […] The first step is to obtain a detailed history to exclude other causes of hepatic steatosis such as alcohol use or exposure to hepatotoxic medications.
  • #13 Non-Alcoholic Fatty Liver Disease | University of Michigan Health
    https://www.uofmhealth.org/conditions-treatments/digestive-and-liver-health/fatty-liver-disease-non-alcoholic
    NAFLD can be separated into two categories: […] NASH is a progressive form of NAFLD where inflammation causes liver damage and scarring (fibrosis). […] Patients who develop cirrhosis are at risk for complications including liver failure and liver cancer (hepatocellular carcinoma). […] In addition to liver-related complications, patients with NAFLD and NASH are also at higher-than-usual risk for cardiovascular disease. […] Diagnosis is typically made if testing for other causes of liver disease is negative and there are findings of fat deposition on imaging tests (like ultrasound, CAT scan or MRI). […] Liver biopsy is the only way to accurately differentiate between NAFLD and NASH. […] Active research is ongoing, but for now there are no FDA approved medications specifically for the treatment of NAFLD/NASH.
  • #14 Non-alcoholic fatty liver disease: leading the fight in primary care | British Journal of General Practice
    https://bjgp.org/content/72/723/499
    GPs are no strangers to non-alcoholic fatty liver disease (NAFLD) and are commonly faced with non-specific liver function tests (LFTs) or an incidental finding of steatosis on ultrasound scan (USS). […] The majority of diagnoses occur in primary care, where clinicians can identify those at risk, initiate investigations, and advise regarding modifiable lifestyle factors. […] NAFLD usually presents with either deranged LFTs or an incidental finding on an USS; however, the majority of patients with NAFLD have normal LFTs. […] Current recommendations are for patients with deranged LFTs, regardless of metabolic risk factors, to have a full non-invasive liver screen. […] The BSG, with representation from the Royal College of General Practitioners, have developed an algorithm for clinicians to use when determining the aetiology of liver pathology.
  • #15
    https://www.nursingcenter.com/journalarticle?Article_ID=5473730&Journal_ID=54016&Issue_ID=5473671
    Nonalcoholic fatty liver disease (NAFLD) is defined as storage of excess fat in the liver not caused by heavy alcohol consumption. Nonalcoholic steatohepatitis is the severe form of NAFLD. This article discusses causes, diagnosis, and nursing interventions for patients with either disorder. […] This article discusses causes, diagnosis, and nursing interventions for patients with NAFLD and NASH. […] A fundamental component of NAFLD and NASH management is lifestyle modification. Importantly, this includes avoiding alcohol, a known hepatotoxin, to prevent further liver damage. […] Nurses are in a strategic position to educate patients, caregivers, and families about NAFLD and NASH. Collaborating with healthcare team members in other disciplines, nurses can work with patients and families to develop a practical plan of care that will help patients lose and maintain weight, make informed dietary choices, and manage comorbidities such as diabetes.
  • #16 Nonalcoholic fatty liver disease – Diagnosis and treatment – Mayo Clinic
    https://www.mayoclinic.org/diseases-conditions/nonalcoholic-fatty-liver-disease/diagnosis-treatment/drc-20354573
    Our caring team of Mayo Clinic experts can help you with your nonalcoholic fatty liver disease-related health concerns […] Treatment for NAFLD usually starts with weight loss. This can be done by eating a healthy diet, limiting portion sizes and exercise. Losing weight may improve other health problems that lead to NAFLD. Typically, losing 10% of your body weight or more is recommended. But losing even 3% to 5% of your starting weight can have benefits. Weight-loss surgery or medicines also may be helpful for certain people. […] With help from your health care team, you can take steps to manage nonalcoholic fatty liver disease. You can: […] If you’re overweight or obese, reduce the number of calories you eat each day and increase your physical activity to lose weight slowly. Eating fewer calories is key to losing weight and managing this disease. If you tried to lose weight in the past and couldn’t, ask your health care team for help.
  • #17 Nonalcoholic fatty liver – La Crosse – Mayo Clinic Health System
    https://www.mayoclinichealthsystem.org/locations/la-crosse/services-and-treatments/gastroenterology-and-hepatology/digestive-disorders/nonalcoholic-fatty-liver-disease
    The first line of treatment is usually weight loss through a combination of a healthy diet and exercise. You can: Lose weight. If you’re overweight or obese, reduce the number of calories you eat each day and increase your physical activity in order to lose weight. Calorie reduction is the key to losing weight and managing this disease. If you have tried to lose weight in the past and have been unsuccessful, ask your doctor for help. Choose a healthy diet. Eat a healthy diet that’s rich in fruits, vegetables and whole grains. Exercise and be more active. Aim for at least 30 minutes of exercise most days of the week. If you’re trying to lose weight, you might find that more exercise is helpful. But if you don’t already exercise regularly, get your doctor’s OK first and start slowly. Control your diabetes. Follow your doctor’s instructions to stay in control of your diabetes. Take your medications as directed and closely monitor your blood sugar. Lower your cholesterol. A healthy plant-based diet, exercise and medications can help keep your cholesterol and your triglycerides at healthy levels. Protect your liver. Avoid things that will put extra stress on your liver. For instance, don’t drink alcohol. Follow the instructions on all medications and over-the-counter drugs. Check with your doctor before using any herbal remedies, as not all herbal products are safe.
  • #18 Nursing Care Plan for Cirrhosis (Liver) | Free NURSING.com Courses
    https://nursing.com/lesson/nursing-care-plan-for-cirrhosis-liver
    Non-Alcoholic Fatty Liver Disease (NAFLD): Accumulation of fat in the liver, often associated with obesity and metabolic syndrome, can progress to cirrhosis. […] Nursing Assessment for Cirrhosis: Obtain a detailed medical history, including alcohol consumption, viral hepatitis, and exposure to liver-toxic substances. […] Evaluate and document symptoms such as fatigue, abdominal pain, nausea, vomiting, and changes in bowel habits. […] Assess the patient’s nutritional status, focusing on dietary habits, weight changes, and signs of malnutrition. […] Monitor fluid balance, paying attention to the presence of ascites, edema, or other signs of fluid retention. […] Review liver function tests, including serum bilirubin, albumin, and prothrombin time, to assess the degree of liver dysfunction.
  • #19 Nursing Care Plan for Cirrhosis (Liver) | Free NURSING.com Courses
    https://nursing.com/lesson/nursing-care-plan-for-cirrhosis-liver
    Assess mental status for signs of hepatic encephalopathy, such as confusion, altered consciousness, or personality changes. […] Examine the skin for jaundice, bruising, and signs of pruritus, which may indicate impaired liver function. […] Perform a thorough abdominal examination to detect hepatomegaly, splenomegaly, or signs of ascites. […] Conduct a psychosocial assessment to identify stressors, coping mechanisms, and support systems. […] Screen for current or past substance use, including alcohol, illicit drugs, or prescription medications. […] Perform a cardiovascular assessment, focusing on blood pressure, heart rate, and signs of fluid overload or compromise. […] Implement strict fluid balance monitoring to manage ascites and prevent dehydration. […] Collaborate with a dietitian to develop a nutrition plan based on the patient’s dietary preferences and restrictions.
  • #20 Nonalcoholic fatty liver disease – Diagnosis and treatment – Mayo Clinic
    https://www.mayoclinic.org/diseases-conditions/nonalcoholic-fatty-liver-disease/diagnosis-treatment/drc-20354573
    Your health care team may suggest avoiding or limiting certain foods and drinks, such as white bread, red and processed meats, juices, and sweetened drinks. […] Aim for at least 150 minutes of exercise a week. If you’re trying to lose weight, you might find that more exercise is helpful. […] Follow your health care team’s advice to manage your diabetes. Take your medicines as told by your care team and watch your blood sugar closely. […] Improve your cholesterol levels and blood pressure if they are high. A healthy diet, exercise and medicines can help keep your cholesterol, triglycerides and blood pressure at healthy levels. […] Avoid things that could harm your liver health. For example, don’t drink alcohol. Follow the instructions on all medicines and nonprescription drugs. Check with your health care team before using any herbal supplements, as some can harm the liver.
  • #21 Nursing Care Plan for Cirrhosis (Liver) | Free NURSING.com Courses
    https://nursing.com/lesson/nursing-care-plan-for-cirrhosis-liver
    Administer prescribed medications, such as diuretics, lactulose, and medications to manage complications like portal hypertension. […] Educate the patient and family about the nature of cirrhosis, treatment options, and the importance of adherence to medical recommendations. […] Malnutrition is often a complication of liver disease but may go unnoticed due to an increase in weight. Encourage and educate patients to maintain a diet low in sodium and fat. Avoid alcohol, seek treatment for alcohol dependence.
  • #22 Nursing Care Plan for Cirrhosis (Liver) | Free NURSING.com Courses
    https://nursing.com/lesson/nursing-care-plan-for-cirrhosis-liver
    Assess mental status for signs of hepatic encephalopathy, such as confusion, altered consciousness, or personality changes. […] Examine the skin for jaundice, bruising, and signs of pruritus, which may indicate impaired liver function. […] Perform a thorough abdominal examination to detect hepatomegaly, splenomegaly, or signs of ascites. […] Conduct a psychosocial assessment to identify stressors, coping mechanisms, and support systems. […] Screen for current or past substance use, including alcohol, illicit drugs, or prescription medications. […] Perform a cardiovascular assessment, focusing on blood pressure, heart rate, and signs of fluid overload or compromise. […] Implement strict fluid balance monitoring to manage ascites and prevent dehydration. […] Collaborate with a dietitian to develop a nutrition plan based on the patient’s dietary preferences and restrictions.
  • #23 Nonalcoholic Fatty Liver Disease as a Systemic Disease and the Need for Multidisciplinary Care
    https://www.gutnliver.org/journal/view.html?volume=17&number=6&spage=843
    Nonalcoholic fatty liver disease (NAFLD) is currently the most common chronic liver disease, and there has been a rapid increase in cases worldwide. NAFLD is rapidly becoming the leading cause of hepatocellular carcinoma and is also associated with an increased risk of cardiovascular disease or exacerbation of other organ diseases, thus posing a significant health problem from both a medical and a socioeconomic perspective. NAFLD is a systemic disease and requires the involvement of numerous medical professionals. Multidisciplinary collaboration, in which different professionals within different specialties come together and work together toward a common goal, supports better patient care by integrating perspectives of multiple experts and facilitating the exchange of opinions. […] Due to the large number of potential patients, gastroenterologists and hepatologists cannot manage the patients alone, and collaboration between specialists in various fields, including family doctors, dentists, nutritionists, and pharmacists is required for treatment of NAFLD. This review will discuss NAFLD from the perspective of various specialties and introduce multidisciplinary collaboration.
  • #24 Nonalcoholic Fatty Liver Disease as a Systemic Disease and the Need for Multidisciplinary Care
    https://www.gutnliver.org/journal/view.html?volume=17&number=6&spage=843
    NAFLD has attracted attention as a systemic disease due to its pathogenic mechanism, poor outcomes, and crosstalk with other organs. If NAFLD/NASH and the associated complications are not proactively screened, they may progress unnoticed. […] NAFLD is rapidly becoming the leading cause of hepatocellular carcinoma and is also associated with an increased risk of CVD, thus posing a significant health problem from both a medical and a socioeconomic perspective. NAFLD is a systemic disease and requires the involvement of numerous medical professionals. […] Multidisciplinary collaboration, in which different professions with different specialties come together and work together toward a common goal, supports better patient care by integrating perspectives of multiple experts and facilitating exchange of opinions.
  • #25 Clinical Care Pathway for the Risk Stratification and Management of Patients With Nonalcoholic Fatty Liver Disease
    https://pmc.ncbi.nlm.nih.gov/articles/PMC8819923/
    Care must also be directed at reversing the unfavorable metabolic profile of many patients, as cardiovascular disease is the main driver of morbidity and mortality in this condition (ie, before the development of cirrhosis). […] Given the complexity of care posed by patients with obesity, diabetes, cardiovascular disease, and NAFLD with fibrosis, successful intervention requires a cohesive multidisciplinary team including the primary care physician, an endocrinologist (for patients with diabetes), and gastroenterologist/hepatologist. […] We recommend that management for these patients should focus on lifestyle interventions to modify unfavorable cardiometabolic risk factors. […] We recommend patients should follow a Mediterranean diet, consistent with the AGAs recent Clinical Practice Update.
  • #26 Clinical Care Guidelines & Guidances in NAFLD/NASH – Global Liver Institute
    https://globalliver.org/clinical-care-guidelines-and-guidances-in-nafld-nash/
    Management of NAFLD or NASH should be done with multidisciplinary healthcare teams that include a primary care physician, hepatologist, gastroenterologist, and endocrinologist, as needed. […] Lifestyle modification is the preferred way to manage NAFLD/NASH long-term. […] People with NAFLD should be recommended a diet that leads to a calorie deficit, limiting carbohydrates and saturated fats and encouraging high fiber and unsaturated fats. […] Those with NAFLD should be recommended to an individualized exercise regiment that promotes physical activity and sustainable weight loss. […] All guidelines/guidances emphasize management of concurring diseases and conditions ie. obesity, type 2 diabetes, hypertension, metabolic syndrome, etc. […] Lifestyle modifications are necessary. A combination of proper nutrition and increased physical activity are shown to have positive results on NAFLD/NASH regression.
  • #27 Nonalcoholic Fatty Liver Disease Program | Mount Sinai – New York
    https://www.mountsinai.org/care/liver-diseases/services/nonalcoholic-fatty-liver
    In collaboration with Mount Sinai’s Diabetes Center and our weight loss and bariatric surgery teams, we offer you a multidisciplinary approach to managing advanced nonalcoholic fatty liver disease. […] Your treatment plan may include making changes to your diet and controlling coexisting metabolic syndrome conditions: diabetes or high cholesterol.
  • #28
    https://myhealth.alberta.ca/Health/aftercareinformation/pages/conditions.aspx?hwid=ad1651
    Non-alcoholic fatty liver disease (NAFLD) is the term for conditions in which fat builds up in the liver in people who drink little or no alcohol. […] Treatment focuses on managing related conditions like diabetes and making lifestyle changes, including losing weight if needed, eating a healthy diet, and being more active. […] Follow-up care is a key part of your treatment and safety. […] Lose weight if you need to. Losing even 5% of your weight can make a difference to your health. […] Manage other health problems. These may include diabetes, high blood pressure, and high cholesterol. […] Eat healthy foods. This includes vegetables, fruits, nuts, beans, lean meat, fish, and whole grains. […] Be more active. Try to get at least 2 hours of moderate to vigorous exercise a week. […] Avoid alcohol. Alcohol can damage the liver and cause other health problems.
  • #29 Nonalcoholic Fatty Liver Disease Clinic | Phoenix Children’s Hospital
    https://phoenixchildrens.org/specialties-conditions/nonalcoholic-fatty-liver-disease-clinic
    Its estimated that five to 10 children out of 100 will develop nonalcoholic fatty liver disease. Implementing a healthy lifestyle for our patients is key to treating the disease but we know this takes time. […] To help patients adjust their diet and increase physical activity, we involve a full team of experts: physicians, pediatric nutritionists, psychologists and the CARE Clinic. We follow the patients over time because managing NAFLD is a life-long challenge. […] Because NAFLD can be a life-long challenge, were committed to working with families for the long haul whether thats for a few months or several years.
  • #30 Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
    https://my.clevelandclinic.org/health/diseases/22437-non-alcoholic-fatty-liver-disease
    Contact your provider if you notice changes in your body like being more tired than usual or pain in your upper right abdomen. These changes could mean you’re developing MASH, a serious form of fatty liver disease that can lead to cirrhosis and hepatocellular cancer. […] Lifestyle changes like losing weight and being more active can help keep MASLD from getting worse. Those changes may even reverse the damage done to your liver.
  • #31 Nursing Care Plan for Cirrhosis (Liver) | Free NURSING.com Courses
    https://nursing.com/lesson/nursing-care-plan-for-cirrhosis-liver
    Administer prescribed medications, such as diuretics, lactulose, and medications to manage complications like portal hypertension. […] Educate the patient and family about the nature of cirrhosis, treatment options, and the importance of adherence to medical recommendations. […] Malnutrition is often a complication of liver disease but may go unnoticed due to an increase in weight. Encourage and educate patients to maintain a diet low in sodium and fat. Avoid alcohol, seek treatment for alcohol dependence.
  • #32 Nonalcoholic fatty liver – La Crosse – Mayo Clinic Health System
    https://www.mayoclinichealthsystem.org/locations/la-crosse/services-and-treatments/gastroenterology-and-hepatology/digestive-disorders/nonalcoholic-fatty-liver-disease
    Nonalcoholic fatty liver disease is a term for a range of liver conditions. As the name implies, the main characteristic the disease is too much fat stored in liver cells. […] Some individuals with nonalcoholic fatty liver disease can develop nonalcoholic steatohepatitis, which is an aggressive form of fatty liver disease marked by liver inflammation that may progress to advanced scarring, or cirrhosis, and liver failure. This damage is similar to the damage caused by heavy alcohol use. […] Nonalcoholic fatty liver disease usually causes no signs and symptoms unless cirrhosis is present, including: Abdominal swelling, Lower extremity swelling (edema), Impaired mental abilities (memory, attention, concentration), Yellowing of the skin and eyes (jaundice), Dark urine, Itching (pruritus).
  • #33 Nursing Care Plan for Cirrhosis (Liver) | Free NURSING.com Courses
    https://nursing.com/lesson/nursing-care-plan-for-cirrhosis-liver
    Assess mental status for signs of hepatic encephalopathy, such as confusion, altered consciousness, or personality changes. […] Examine the skin for jaundice, bruising, and signs of pruritus, which may indicate impaired liver function. […] Perform a thorough abdominal examination to detect hepatomegaly, splenomegaly, or signs of ascites. […] Conduct a psychosocial assessment to identify stressors, coping mechanisms, and support systems. […] Screen for current or past substance use, including alcohol, illicit drugs, or prescription medications. […] Perform a cardiovascular assessment, focusing on blood pressure, heart rate, and signs of fluid overload or compromise. […] Implement strict fluid balance monitoring to manage ascites and prevent dehydration. […] Collaborate with a dietitian to develop a nutrition plan based on the patient’s dietary preferences and restrictions.
  • #34 Fatty Liver Disease: Nonalcoholic and Alcoholic Steatohepatitis (NAFLD/AFLD)
    https://www.webmd.com/fatty-liver-disease/fatty-liver-disease
    Fatty liver disease (FLD) means you have extra fat in your liver. You might hear your doctor call it hepatic steatosis. Most of the time, it doesn’t cause symptoms, but over time a buildup of fat makes it harder for your liver to work. […] With diet and exercise, fatty liver disease can be reversed. […] This type used to be called nonalcoholic fatty liver disease (NAFLD). It is very common in the U.S., affecting 1 in 3 adults. […] Unlike the other main type, you don’t get it from drinking alcohol. […] Most people with MASLD have simple fatty liver. […] This used to be known as nonalcoholic steatohepatitis (NASH). It’s the advanced stage of FLD and means you have inflammation in your liver. […] These problems can lead to liver failure and require a liver transplant. […] If you have complications due to either type of FLD, such as cirrhosis or liver failure, you may need to have a liver transplant.
  • #35 Non-Alcoholic Fatty Liver Disease | University of Michigan Health
    https://www.uofmhealth.org/conditions-treatments/digestive-and-liver-health/fatty-liver-disease-non-alcoholic
    NAFLD can be separated into two categories: […] NASH is a progressive form of NAFLD where inflammation causes liver damage and scarring (fibrosis). […] Patients who develop cirrhosis are at risk for complications including liver failure and liver cancer (hepatocellular carcinoma). […] In addition to liver-related complications, patients with NAFLD and NASH are also at higher-than-usual risk for cardiovascular disease. […] Diagnosis is typically made if testing for other causes of liver disease is negative and there are findings of fat deposition on imaging tests (like ultrasound, CAT scan or MRI). […] Liver biopsy is the only way to accurately differentiate between NAFLD and NASH. […] Active research is ongoing, but for now there are no FDA approved medications specifically for the treatment of NAFLD/NASH.
  • #36 Practice Nursing – Non-alcoholic fatty liver disease: a global concern
    https://www.practicenursing.com/content/clinical-focus/non-alcoholic-fatty-liver-disease-a-global-concern/
    Non-alcoholic fatty liver disease is an umbrella term used to describe a build-up of fat in the liver. […] Nurses are often in the best position to prompt early investigation. Health promotion in the form of lifestyle advice is the mainstay of treatment, with an emphasis on weight reduction and healthy diet.
  • #37 Fatty liver — symptoms, causes and treatment | healthdirect
    https://www.healthdirect.gov.au/fatty-liver
    Fatty liver disease is a common condition it occurs in about 1 in every 3 Australian adults. […] It means too much fat has built up in the liver; over time it can lead to liver damage. […] For most people liver damage can be reversed. […] You can improve or prevent this condition with a healthy diet and lifestyle, and reducing alcohol intake. […] Management involves making changes to your lifestyle. This can improve the condition and even reverse it. […] If you have metabolic associated fatty liver disease, you will probably be advised to: follow a healthy diet and avoid sugar, lose weight, exercise regularly, control your blood sugar, treat high cholesterol if you have it, avoid medicines that can affect your liver, drink no or very little alcohol, and quit smoking. […] If your fatty liver is caused by alcohol, then the most important thing to do is give up alcohol. This will prevent you from developing a more serious condition.
  • #38 Fatty liver — symptoms, causes and treatment | healthdirect
    https://www.healthdirect.gov.au/fatty-liver
    The way to prevent metabolic associated fatty liver disease is to follow the same lifestyle advice given to people who already have the condition, including: eating a healthy diet that is rich in fruit and vegetables, whole grains and healthy fats, maintaining a healthy weight, drinking no or very little alcohol, being physically active on most days of the week. […] Being a healthy weight is important to prevent liver disease and, if you already have disease, to prevent it getting worse. If you have fatty liver disease, one of the best things you can do is lose weight. Losing 5 to 10% of your body weight can control and sometimes reverse the disease.
  • #39 Screening for Nonalcoholic Fatty Liver Disease in the Primary Care Clinic – Gastroenterology & Hepatology
    https://www.gastroenterologyandhepatology.net/archives/july-2019/screening-for-nonalcoholic-fatty-liver-disease-in-the-primary-care-clinic/
    Nonalcoholic fatty liver disease (NAFLD) is a spectrum of diseases ranging from simple hepatic steatosis to nonalcoholic steatohepatitis (NASH) to advanced fibrosis and cirrhosis as well as liver cancer. […] It is suggested that patients at high risk for NAFLD be screened in the out-patient setting. […] This article aims to supply primary care providers (PCPs) with the knowledge and tools needed to properly evaluate a patient at high risk of developing significant liver disease from NASH. […] Thus, providing PCPs with guidelines that encourage proper screening and improve identification of patients at high risk for NAFLD is becoming increasingly important, as the prevalence of NAFLD is substantially increasing worldwide. […] The AASLD practice guidance does not recommend NAFLD screening even among high-risk patients with diabetes or obesity.
  • #40 Screening for Nonalcoholic Fatty Liver Disease in the Primary Care Clinic – Gastroenterology & Hepatology
    https://www.gastroenterologyandhepatology.net/archives/july-2019/screening-for-nonalcoholic-fatty-liver-disease-in-the-primary-care-clinic/
    Instead, the use of clinical prediction rules such as the NAFLD Fibrosis Score (NFS), Fibrosis-4 (FIB-4) score, or transient elastography is recommended to risk-stratify patients with a high index of clinical suspicion. […] In contrast to the AASLD practice guidance, the Clinical Practice Guidelines cowritten by EASL, the European Association for the Study of Diabetes, and the European Association for the Study of Obesity do recommend routine screening for NAFLD with liver enzymes and/or ultrasound in all patients with obesity or metabolic syndrome. […] Given the increasing prevalence of NAFLD, the promise of new medications in the near future, and the effects of untreated NAFLD, PCPs should begin screening high-risk patients, including those greater than 50 years of age with type 2 diabetes or metabolic syndrome, for NAFLD.
  • #41 Nonalcoholic Fatty Liver Disease (NAFLD)
    https://liverfoundation.org/liver-diseases/fatty-liver-disease/nonalcoholic-fatty-liver-disease-nafld/
    There are things people can do to lower their chances of developing NAFLD (now called MASLD). […] While NAFLD (now called MASLD) can affect people of all ages, sexes, and ethnicities, it is important to consider its specific implications during pregnancy and in those intending to become pregnant. […] Once NAFLD is determined, management of the condition focuses on lifestyle interventions (health dietary modifications and appropriate physical activities permitted during pregnancy) as there are no approved medications for NAFLD in pregnancy. […] Ultimately, close monitoring during pregnancy is crucial to reduce risks and improve outcomes for both the mother and her child. […] What kinds of dietary and lifestyle changes do you suggest that I make? […] Can you refer me to a registered dietitian or nutritionist to help me plan healthy meals? […] Is there a treatment or medication for NAFLD? Are there any clinical trials that might be good for me?
  • #42 Implementation of a care bundle improves the management of patients with non-alcoholic fatty liver disease | Frontline Gastroenterology
    https://fg.bmj.com/content/12/7/578
    Non-alcoholic fatty liver disease (NAFLD) is common and is associated with liver-related and cardiovascular-related morbidity. Our aims were: (1) to review the current management of patients with NAFLD attending hospital clinics in North East England (NEE) and assess the variability in care; (2) develop a NAFLD care bundle to standardise care; (3) to assess the impact of implementation of the NAFLD care bundle. […] The introduction of an outpatient care bundle led to significant improvements in the assessment and management of patients with NAFLD in the NEE and could help improve and standardise care if used more widely. […] Introduction of a care bundle into routine outpatient clinics may help improve and standardise the management of NAFLD. […] Completion of the bundle may ensure that all metabolic risk factors are addressed.
  • #43 Implementation of a care bundle improves the management of patients with non-alcoholic fatty liver disease | Frontline Gastroenterology
    https://fg.bmj.com/content/12/7/578
    Non-alcoholic fatty liver disease (NAFLD) is common and is associated with liver-related and cardiovascular-related morbidity. Our aims were: (1) to review the current management of patients with NAFLD attending hospital clinics in North East England (NEE) and assess the variability in care; (2) develop a NAFLD care bundle to standardise care; (3) to assess the impact of implementation of the NAFLD care bundle. […] The introduction of an outpatient care bundle led to significant improvements in the assessment and management of patients with NAFLD in the NEE and could help improve and standardise care if used more widely. […] Introduction of a care bundle into routine outpatient clinics may help improve and standardise the management of NAFLD. […] Completion of the bundle may ensure that all metabolic risk factors are addressed.
  • #44 Implementation of a care bundle improves the management of patients with non-alcoholic fatty liver disease | Frontline Gastroenterology
    https://fg.bmj.com/content/12/7/578
    The bundle provides a standardised approach to record key information such as anthropometry, stage of liver disease and metabolic risk factors. Moreover, the care bundle provides a treatment algorithm and a checklist to ensure lifestyle advice and treatment goals are more clearly documented, and metabolic risk factors are actively managed. […] Our study of the care bundle implementation in general hepatology clinics demonstrated that in individuals where the care bundle was used, key aspects of management were significantly more likely to be addressed and documented. […] In response to this, we developed a care bundle to standardise care and promote the active management of NAFLD and its associated metabolic risk factors. Our data have demonstrated that use of the NAFLD bundle significantly improved the holistic care of patients with NAFLD.
  • #45 Implementation of a care bundle improves the management of patients with non-alcoholic fatty liver disease | Frontline Gastroenterology
    https://fg.bmj.com/content/12/7/578
    The bundle provides a standardised approach to record key information such as anthropometry, stage of liver disease and metabolic risk factors. Moreover, the care bundle provides a treatment algorithm and a checklist to ensure lifestyle advice and treatment goals are more clearly documented, and metabolic risk factors are actively managed. […] Our study of the care bundle implementation in general hepatology clinics demonstrated that in individuals where the care bundle was used, key aspects of management were significantly more likely to be addressed and documented. […] In response to this, we developed a care bundle to standardise care and promote the active management of NAFLD and its associated metabolic risk factors. Our data have demonstrated that use of the NAFLD bundle significantly improved the holistic care of patients with NAFLD.
  • #46
    https://journals.lww.com/nursing/fulltext/2020/03000/nonalcoholic_fatty_liver_disease__what_nurses_need.11.aspx
    Nonalcoholic fatty liver disease: What nurses need to know […] GENERAL PURPOSE: To provide an overview of NAFLD. […] LEARNING OBJECTIVES/OUTCOMES: After completing this continuing-education activity, you should be able to: 1. Describe risk factors for NAFLD. 2. List the clinical manifestations of NAFLD. 3. Outline nursing interventions for patients with NAFLD. […] […] […] Nutritional recommendations for patients with NAFLD include having 40% to 50% of total dietary intake comprised of carbohydrates. […] […] […] Which of the following supplements does the AASLD recommend considering for adults without diabetes who have biopsy-proven NASH? vitamin E. […] […] […] A diet rich in which of the following has been proven beneficial for patients with NAFLD and NASH? whole grains. […] […] […] To resolve mild-to-moderate fibrosis, the AASLD recommends that patients reduce body weight by 5%.
  • #47 NCQA White Paper: Improving Coordinated Care for People With Nonalcoholic Steatohepatitis – NCQA
    https://www.ncqa.org/blog/ncqa-white-paper-improving-coordinated-care-for-people-with-nonalcoholic-steatohepatitis/
    The costs of fatty liver disease are considerable. NASH increases the risk of advanced liver disease that can lead to liver failure, making it the second most common cause of liver transplants in the U.S. […] The American Association for the Study of Liver Diseases advises that there should be a high index of suspicion of NAFLD and NASH among patients with T2DM. […] Roundtable panelists recommended that clinician education on NASH be shared alongside other obesity-related conditions, including a greater leadership role by professional societies, and within medical school curricula.
  • #48 2022 Clinical Practice Guideline for the Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Primary Care and Endocrinology Clinical Settings | American Association of Clinical Endocrinology
    https://pro.aace.com/clinical-guidance/2022-clinical-practice-guideline-diagnosis-and-management-nonalcoholic
    This guideline provides evidence-based recommendations regarding the diagnosis and management of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) to endocrinologists, primary care clinicians, health care professionals, and other stakeholders. […] Key topics include screening for NAFLD/NASH, and the latest management recommendations including supplements, medications, bariatric surgery, and more. […] Learn how to apply our AACE guideline to your practice by registering for our complimentary course, MASLD and MASH: Early Identification to Decrease Associated Complications.
  • #49 Cost-Effectiveness Analysis: Risk Stratification of Nonalcoholic Fatty Liver Disease (NAFLD) by the Primary Care Physician Using the NAFLD Fibrosis Score | PLOS One
    https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0147237
    The complications of Nonalcoholic Fatty Liver Disease (NAFLD) are dependent on the presence of advanced fibrosis. […] Accordingly, a major focus of clinical care for patients with NAFLD should be the determination of those at highest risk for the complications of advanced liver disease. […] The optimal strategy for the management of NAFLD would benefit from a multidisciplinary approach to prioritize patients for specialists referral. […] Increasingly, reports are identifying the feasibility of screening for advanced liver disease in the primary care setting. […] Herein, this study compares the cost-effectiveness of multiple strategies for the evaluation of patients with NAFLD in the primary care clinic or the referral setting using the NFS, VCTE, and their combination to the current standard of percutaneous liver biopsy.
  • #50 Cost-Effectiveness Analysis: Risk Stratification of Nonalcoholic Fatty Liver Disease (NAFLD) by the Primary Care Physician Using the NAFLD Fibrosis Score | PLOS One
    https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0147237
    The non-invasive evaluation of NAFLD using the NFS with or without VCTE is a cost-effective strategy for the patient-centered risk stratification of an increasingly common disease. […] These data demonstrate that tremendous costs are saved when a model of NAFLD care is applied where primary care physicians would recognize and manage early disease, referring to gastroenterologists the patients with advanced liver disease. […] In conclusion, both the NFS and the combination of NFS with VCTE are biopsy-sparing, cost-effective tools in the evaluation and management of NAFLD in the primary care setting.
  • #51 Screening for Nonalcoholic Fatty Liver Disease in the Primary Care Clinic – Gastroenterology & Hepatology
    https://www.gastroenterologyandhepatology.net/archives/july-2019/screening-for-nonalcoholic-fatty-liver-disease-in-the-primary-care-clinic/
    A similar strategy was proposed in a study by Tapper and Lok, suggesting that PCPs could play a key role in both identifying at-risk patients and reducing the overall economic burden of NAFLD. […] As NAFLD and NASH become more prevalent, knowledge of disease etiology, screening, and detection methods among PCPs becomes increasingly important.
  • #52 NCQA White Paper: Improving Coordinated Care for People With Nonalcoholic Steatohepatitis – NCQA
    https://www.ncqa.org/blog/ncqa-white-paper-improving-coordinated-care-for-people-with-nonalcoholic-steatohepatitis/
    Nonalcoholic fatty liver disease (NAFLD) is characterized by accumulation of fat in the liver (hepatic steatosis) among people who do not consume significant amounts of alcohol. […] Identifying patients with NASH early in the disease process is essential to optimized care, including patient engagement in nutrition and lifestyle counseling to achieve and maintain weight loss goals. […] The white paper offers guidance on overcoming barriers to ideal care, including recommendations for culturally appropriate patient education and best practices for overcoming disparities in care, such as the strategies discussed in NCQA’s new Health Equity Resource Center. […] As awareness of NASH and familiarity with existing screening tools expands, clinicians will begin to identify more at-risk patients.
  • #53 Nonalcoholic Fatty Liver Disease (NAFLD)
    https://liverfoundation.org/liver-diseases/fatty-liver-disease/nonalcoholic-fatty-liver-disease-nafld/
    There are things people can do to lower their chances of developing NAFLD (now called MASLD). […] While NAFLD (now called MASLD) can affect people of all ages, sexes, and ethnicities, it is important to consider its specific implications during pregnancy and in those intending to become pregnant. […] Once NAFLD is determined, management of the condition focuses on lifestyle interventions (health dietary modifications and appropriate physical activities permitted during pregnancy) as there are no approved medications for NAFLD in pregnancy. […] Ultimately, close monitoring during pregnancy is crucial to reduce risks and improve outcomes for both the mother and her child. […] What kinds of dietary and lifestyle changes do you suggest that I make? […] Can you refer me to a registered dietitian or nutritionist to help me plan healthy meals? […] Is there a treatment or medication for NAFLD? Are there any clinical trials that might be good for me?
  • #54 Fatty Liver Disease: Nonalcoholic and Alcoholic Steatohepatitis (NAFLD/AFLD)
    https://www.webmd.com/fatty-liver-disease/fatty-liver-disease
    Usually the first line of treatment is to lose excess weight. It helps reduce fat, inflammation, and scarring in your liver. […] And whether you have MASLD or ALD, you’ll also need to not drink alcohol. […] FLD can be reversed if you avoid alcohol and take steps to get to a healthy weight. […] Lifestyle changes can help: […] Changing the way you eat can help to lessen or reverse MASLD or MASH. […] Fatty liver disease and children: About 10% of children in the U.S. have MASLD and numbers are growing as the number of kids who have obesity grows. […] But most children with MASLD don’t get liver problems and MASLD can be controlled or reversed if your child becomes more active, loses excess weight, and has an improvement in their eating habits and nutrition.
  • #55 Non-Alcoholic Fatty Liver Disease (NAFLD): Causes, Symptoms & Treatment | Nationwide Children’s Hospital
    https://www.nationwidechildrens.org/conditions/nonalcoholic-fatty-liver-disease
    Fatty liver disease occurs when too much fat builds up in the liver. Excess fat in the liver and elsewhere in the body makes it harder for the liver to work well. […] Our Liver Center expertly cares for children with non-alcoholic fatty liver disease. […] Right now, there are no medicines to treat NAFL (the simple, uncomplicated form of NAFLD) in children. Weight loss is the main treatment. With proper diet and exercise, it is often possible to reverse NAFL. Even for the severe form of NAFLD, called NASH, the main treatment is weight loss through diet and exercise. […] Weight loss is the main treatment for NAFLD. […] Rarely, NASH may need treatment with medicines or surgery. […] Patients with liver failure due to NASH may need a liver transplant.
  • #56 Nonalcoholic Fatty Liver Disease (NAFLD)
    https://liverfoundation.org/liver-diseases/fatty-liver-disease/nonalcoholic-fatty-liver-disease-nafld/
    There are things people can do to lower their chances of developing NAFLD (now called MASLD). […] While NAFLD (now called MASLD) can affect people of all ages, sexes, and ethnicities, it is important to consider its specific implications during pregnancy and in those intending to become pregnant. […] Once NAFLD is determined, management of the condition focuses on lifestyle interventions (health dietary modifications and appropriate physical activities permitted during pregnancy) as there are no approved medications for NAFLD in pregnancy. […] Ultimately, close monitoring during pregnancy is crucial to reduce risks and improve outcomes for both the mother and her child. […] What kinds of dietary and lifestyle changes do you suggest that I make? […] Can you refer me to a registered dietitian or nutritionist to help me plan healthy meals? […] Is there a treatment or medication for NAFLD? Are there any clinical trials that might be good for me?
  • #57 Non-alcoholic fatty liver disease: leading the fight in primary care | British Journal of General Practice
    https://bjgp.org/content/72/723/499
    Serum fibrosis markers should be used to rule out significant fibrosis. […] A FIB-4 score of 1.3 (2.0 if 65 years) or NFS 1.455 (0.120 if 65 years) indicates low risk of advanced fibrosis and can be managed in primary care. […] There is currently no approved treatment for NAFLD and the number of patients experiencing adverse liver outcomes is small, raising questions on the benefits of population screening until there are effective, evidence-based therapies available to prevent progression. […] If a patient has NAFLD but does not meet the threshold for referral, reassessment should occur every 3 years. […] GPs exposure to patients at risk is on an upward trajectory.
  • #58 Fatty Liver Disease Care | AdventHealth Digestive Health Institute
    https://institute.adventhealth.com/digestive-health/central-florida/fatty-liver-disease-care
    This webinar will explore a step-by-step approach to overcome nonalcoholic fatty liver disease. Further it will outline tangible and realistic goals to optimize liver health. […] This webinar will discuss dietary management of nonalcoholic fatty liver disease. The pros and cons of dietary recommendations will be explored to aid in the decision of which dietary choice is best suited for each patient. […] Our AdventHealth Digestive Health Institute wants to help. Below, youll find multiple downloadable resources and avenues to understand fatty liver disease and your roadmap to future health.
  • #59 Nonalcoholic Fatty Liver Disease (NAFLD) Symptoms & Treatment | BASS Medical Group
    https://www.bassmedicalgroup.com/blog-post/how-to-spot-nonalcoholic-fatty-liver-disease
    Nonalcoholic fatty liver disease (NAFLD) is a condition where excess fat builds up in the liver cells of people who drink little to no alcohol. Its one of the most common liver disorders in the U.S., affecting over 25% of Americans. While the condition is often silent, it can lead to serious complications like cirrhosis and liver failure if left untreated. […] NAFLD is preventable and manageable with early detection and lifestyle changes. […] If you live with any of these conditions, talk to your primary care provider or endocrinologist about liver screening. […] If NAFLD progresses to advanced fibrosis or cirrhosis, you may need to consult a hepatologist, gastroenterologist, or endocrinologist. […] Early detection is key to preventing liver damage. If you have risk factors or experience symptoms like fatigue, abdominal swelling, or jaundice, dont wait. […] At BASS Medical Group, we take a collaborative approach to managing liver health. Whether you need a diagnosis, lifestyle guidance, or advanced care for liver disease, our expert providers are here to support you.
  • #60 Fatty Liver Disease Care | AdventHealth Digestive Health Institute
    https://institute.adventhealth.com/digestive-health/central-florida/fatty-liver-disease-care
    This webinar will explore a step-by-step approach to overcome nonalcoholic fatty liver disease. Further it will outline tangible and realistic goals to optimize liver health. […] This webinar will discuss dietary management of nonalcoholic fatty liver disease. The pros and cons of dietary recommendations will be explored to aid in the decision of which dietary choice is best suited for each patient. […] Our AdventHealth Digestive Health Institute wants to help. Below, youll find multiple downloadable resources and avenues to understand fatty liver disease and your roadmap to future health.
  • #61 Nonalcoholic Fatty Liver Disease (NAFLD) Symptoms & Treatment | BASS Medical Group
    https://www.bassmedicalgroup.com/blog-post/how-to-spot-nonalcoholic-fatty-liver-disease
    Nonalcoholic fatty liver disease (NAFLD) is a condition where excess fat builds up in the liver cells of people who drink little to no alcohol. Its one of the most common liver disorders in the U.S., affecting over 25% of Americans. While the condition is often silent, it can lead to serious complications like cirrhosis and liver failure if left untreated. […] NAFLD is preventable and manageable with early detection and lifestyle changes. […] If you live with any of these conditions, talk to your primary care provider or endocrinologist about liver screening. […] If NAFLD progresses to advanced fibrosis or cirrhosis, you may need to consult a hepatologist, gastroenterologist, or endocrinologist. […] Early detection is key to preventing liver damage. If you have risk factors or experience symptoms like fatigue, abdominal swelling, or jaundice, dont wait. […] At BASS Medical Group, we take a collaborative approach to managing liver health. Whether you need a diagnosis, lifestyle guidance, or advanced care for liver disease, our expert providers are here to support you.
  • #62
    https://www.nursingcenter.com/journalarticle?Article_ID=5473730&Journal_ID=54016&Issue_ID=5473671
    Nonalcoholic fatty liver disease (NAFLD) is defined as storage of excess fat in the liver not caused by heavy alcohol consumption. Nonalcoholic steatohepatitis is the severe form of NAFLD. This article discusses causes, diagnosis, and nursing interventions for patients with either disorder. […] This article discusses causes, diagnosis, and nursing interventions for patients with NAFLD and NASH. […] A fundamental component of NAFLD and NASH management is lifestyle modification. Importantly, this includes avoiding alcohol, a known hepatotoxin, to prevent further liver damage. […] Nurses are in a strategic position to educate patients, caregivers, and families about NAFLD and NASH. Collaborating with healthcare team members in other disciplines, nurses can work with patients and families to develop a practical plan of care that will help patients lose and maintain weight, make informed dietary choices, and manage comorbidities such as diabetes.
  • #63 Clinical care pathway for the risk stratification and management of patients with nonalcoholic fatty liver disease (NAFLD) – American Gastroenterological AssociationAGA Logo_Horizontal
    https://gastro.org/clinical-guidance/clinical-care-pathway-for-the-risk-stratification-and-management-of-patients-with-nonalcoholic-fatty-liver-disease-nafld/
    AGA convened international experts in nonalcoholic fatty liver disease (NAFLD) to outline the spectrum of care from screening and diagnosis to patient care management. […] Step 1: Identifying patients with clinically significant hepatic fibrosis (fibrosis stage 2 or higher) is important for targeted efforts at preventing disease progression. These groups include patients with type 2 diabetes, patients with two or more metabolic risk factors, and those with incidental findings of hepatic steatosis or elevated amino transferases. […] A multidisciplinary team, including a primary care provider, an endocrinologist for patients with diabetes, and a gastroenterologist/hepatologist, is needed to successfully manage the complexity of care posed by high-risk patients due to obesity, diabetes, CVD and NALFD with fibrosis. The primary goal of screening these patients is to implement early interventions to prevent the development of cirrhosis and liver-related and all-cause mortality.
  • #64 Clinical care pathway for the risk stratification and management of patients with nonalcoholic fatty liver disease (NAFLD) – American Gastroenterological AssociationAGA Logo_Horizontal
    https://gastro.org/clinical-guidance/clinical-care-pathway-for-the-risk-stratification-and-management-of-patients-with-nonalcoholic-fatty-liver-disease-nafld/
    Patients at low-risk of advanced fibrosis should be managed using therapeutic lifestyle interventions, such as weight loss, as appropriate, nutritional strategies, stress management, regular physical exercise and avoiding excess alcohol intake. […] Patients at high-risk advanced fibrosis should be managed by a multidisciplinary team closely coordinated by a hepatologist who can monitor for cirrhosis, hepatocellular carcinoma and other cirrhosis-related complications. […] Patients at indeterminate-risk of advanced fibrosis should be managed using a similar approach to high-risk patients, along with further work-up and efforts to confirm the stage of hepatic fibrosis.
  • #65 Nonalcoholic fatty liver disease: MedlinePlus Medical EncyclopediaLock
    https://medlineplus.gov/ency/article/007657.htm
    Lowering your cholesterol and triglyceride levels. […] Taking medicines as directed. Talk to your provider about all medicines you take, including herbs and supplements and over-the-counter medicines. […] Losing weight and managing diabetes can slow or sometimes reverse the deposit of fat in the liver. […] Many people with NAFLD have no health problems and do not go on to develop NASH. Losing weight and making healthy lifestyle choices can help prevent more serious problems. […] Most people with NAFLD do not know they have it. See your provider if you begin to have unusual symptoms such as fatigue or abdominal pain. […] To help prevent NAFLD: […] Maintain a healthy weight. […] Eat a healthy diet. […] Exercise regularly. […] Limit alcohol consumption. […] Use medicines properly.